JOANN VITIELLO: Open Payments
NPI 1861734139 · MARICOPA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 30 payments from 10 companies in 2025. Trend: 2023 $1,732 · 2024 $1,642 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $288 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $175 |
| AstraZeneca Pharmaceuticals LP | 3 | $173 |
| REVANCE THERAPEUTICS, INC. | 1 | $149 |
| Lilly USA, LLC | 3 | $61 |
| Novo Nordisk Inc | 3 | $57 |
| Lundbeck LLC | 2 | $41 |
| Boston Scientific Corporation | 1 | $20 |
| Abbott Laboratories | 1 | $18 |
| PFIZER INC. | 1 | $15 |
Products named: CAPLYTA, DAXI, BREZTRI, Wegovy, VRAYLAR, REXULTI, QULIPTA, FARXIGA.
Industry payments across AZ — which companies pay providers there.
